Aryl(methoxycarbonyl)nitrile imines
Russ.Chem.Bull., Int.Ed., Vol. 59, No. 7, July, 2010
1391
Methyl 5ꢀcyclopropylꢀ1ꢀ(4ꢀfluorophenyl)ꢀ4,5ꢀdihydroꢀ1Hꢀ
pyrazoleꢀ3ꢀcarboxylate (8a) and methyl 5ꢀcyclopropylꢀ1ꢀ(4ꢀ
fluorophenyl)ꢀ1Hꢀpyrazoleꢀ3ꢀcarboxylate (9a). Dihydroindꢀ
azole 2a (0.24 g) and vinylcyclopropane (0.27 g) gave pyrazoline
8a (53 mg, ~50%) and pyrazole 9a (23 mg, 22%), each of which
is enriched with the major substance by 93—95%.
(C(4)); 114.2 (Cm); 126.9 (Co); 132.6 (Cipso); 143.2 (C(3)); 147.9
(C(5)); 159.7 (Cp); 163.4 (COO).
Methyl 5ꢀethoxyꢀ1ꢀ(4ꢀfluorophenyl)ꢀ4,5ꢀdihydroꢀ1Hꢀpyrꢀ
azoleꢀ3ꢀcarboxylate (10) and methyl 1ꢀ(4ꢀfluorophenyl)ꢀ1Hꢀpyrꢀ
azoleꢀ3ꢀcarboxylate (11). Dihydroindazole 2a (0.24 g, 0.4 mmol)
and ethyl vinyl ether (1.73 g, 24 mmol) after separation by colꢀ
umn chromatography on SiO2 (benzene—EtOAc, 8 : 1) gave
a mixture of 10 and 11 (30 mg, molar ratio 1 : 0.7) and pyrazole
11 (41 mg), the total yield of which was ~60%.
Compound 8a. IR, ν/cm–1: 2958, 1700 (COO), 1508. MS
(EI), m/z (Irel (%)): 262 [M]+ (10), 221 (5), 189 (16), 177 (10),
122 (12), 109 (100). 1H NMR (CDCl3), δ: 0.26, 0.41, 0.52, 0.65
(all m, 1 H each, CH2CH2); 1.07 (m, 1 H, CH in cycloꢀC3H5);
3.03 (dd, 1 H, Ha(4), 2J = 17.9 Hz, 3J = 6.0 Hz); 3.31 (dd, 1 H,
Hb(4), 2J = 17.9 Hz, 3J = 12.0 Hz); 3.90 (s, 3 H, OMe); 4.09
(ddd, 1 H, H(5), 3J = 6.0 Hz, 7.9 Hz, J = 12.0 Hz); 7.00 (dd, 2 H,
Compound 10. GLCꢀMS (EI), m/z (Irel (%)): 266 [M]+ (50),
235 [M – OMe]+ (10), 221 [M – OEt]+ (70), 190 (60), 177 (30),
109 (100). 1H NMR (CDCl3), δ: 1.12 (t, 3 H, Me, 3J = 7.0 Hz);
3.18—3.39 (m, 4 H, H2C(4), OCH2); 3.89 (s, 3 H, OMe); 5.83
(dd, 1 H, H(5), 3J = 3.5 Hz, 3J = 8.7 Hz); 7.01 (dd, 2 H, Hm,
3JH,H = 8.9 Hz, 3JH,F = 8.2 Hz); 7.30 (dd, 2 H, Ho, 3JH,H = 8.9
Hm, 3JH,H = 9.1 Hz, 3JH,F = 8.6 Hz); 7.24 (dd, 2 H, Ho, 3JH,H
=
4
= 9.1 Hz, JH,F = 4.5 Hz). 13C NMR (CDCl3), δ: 1.9, 6.3
4
(CH2CH2); 15.3 (CH in cycloꢀC3H5); 37.9 (C(4)); 52.2 (OMe);
Hz, JH,F = 4.8 Hz). 13C NMR (CDCl3), δ: 15.0 (Me); 37.0
66.2 (C(5)); 115.7 (d, Cm, 2JC,F = 22.5 Hz); 117.8 (d, Co, 3JC,F
=
(C(4)); 52.3 (OMe); 59.1 (OCH2); 88.8 (C(5)); 115.8 (d, Cm,
4
3
= 8.0 Hz); 137.8 (d, Cipso, JC,F = 2.2 Hz); 138.5 (C(3)); 160.0
2JC,F = 22.5 Hz); 116.2 (Co, JC,F = 8.0 Hz); 138.0 (d, Cipso
,
1
1
(COO); 160.1 (d, Cp, JC,F = 242 Hz). 19F NMR (CDCl3), δ:
4JC,F = 2.3 Hz); 139.0 (C(3)); 158.1 (d, Cp, JC,F = 243 Hz);
–122.8 (tt, 3J = 8.6 Hz, 4J = 4.5 Hz).
162.7 (COO).
Compound 9a. IR, ν/cm–1: 2958, 1724 (COO), 1516. MS
(EI), m/z (Irel (%)): 260 [M]+ (10), 229 [M – OMe]+ (90), 213
(10), 201 [M – COOMe]+ (12), 161 (12), 134 (15), 105 (50), 95
(100). 1H NMR (CDCl3), δ: 0.81, 1.01 (both m, 2 H each,
Compound 11, colorless crystals, m.p. 101—102 °C (from
C6H6). Found (%): C, 60.24; H, 4.08; N, 12.51. C11H9FN2O2.
Calculated (%): C, 60.00; H, 4.12; N, 12.72. MS (EI), m/z
(Irel (%)): 220 [M]+ (50), 189 [M – OMe]+ (71), 162 (25), 134
(45), 107 (40), 95 (100). IR, ν/cm–1: 2960, 1724 (COO), 1522,
1504. 1H NMR (CDCl3), δ: 3.99 (s, 3 H, OMe); 5.83 (dd, 1 H,
H(5), 3J = 3.5 Hz, 3J = 8.7 Hz); 7.00 (d, 1 H, H(4), 3J = 2.4 Hz);
7.17 (dd, 2 H, Hm, 3JH,H = 8.9 Hz, 3JH,F = 8.1 Hz); 7.71 (dd, 2 H,
Ho, 3JH,H = 8.9 Hz, 4JH,F = 4.9 Hz); 7.88 (d, 1 H, H(5), 3J= 2.4 Hz).
CH2CH2); 1.74 (tt, 1 H, CH in cycloꢀC3H5, Jcis = 8.5 Hz, Jtrans
=
= 5.2 Hz); 3.95 (s, 3 H, OMe); 6.50 (s, 1 H, H(4)); 7.18 (dd, 2 H,
Hm, 3JH,H = 9.0 Hz, 3JH,F = 8.3 Hz); 7.60 (dd, 2 H, Ho, 3JH,H
=
4
= 9.0 Hz, JH,F = 4.8 Hz). 13C NMR (CDCl3), δ: 7.5 (CH in
cycloꢀC3H5); 9.1 (CH2CH2); 52.1 (OMe); 105.3 (C(4)); 116.1
2
3
(d, Cm, JC,F = 22.7 Hz); 127.3 (d, Co, JC,F = 8.3 Hz); 135.6
13C NMR (CDCl3), δ: 52.2 (OMe); 110.6 (C(4)); 116.4 (d, Cm,
3
(d, Cipso
,
4JC,F = 2.2 Hz); 143.6 (C(3)); 147.9 (C(5)); 162.4
2JC,F = 22.7 Hz); 122.1 (Co, JC,F = 8.5 Hz); 136.0 (d, Cipso
,
1
(d, Cp, JC,F = 248 Hz); 162.9 (COO). 19F NMR (CDCl3), δ:
4JC,F = 2.2 Hz); 144.9 (C(3)); 147.9 (C(5)); 161.8 (d, Cp, 1JC,F
=
= 244 Hz); 162.6 (COO). 19F NMR (CDCl3), δ: –114.7 (tt, 3J =
–113.3 (tt, 3J = 8.3 Hz, 4J = 4.8 Hz).
Methyl 5ꢀcyclopropylꢀ1ꢀ(4ꢀmethoxyphenyl)ꢀ4,5ꢀdihydroꢀ1Hꢀ
pyrazoleꢀ3ꢀcarboxylate (8b) and methyl 5ꢀcyclopropylꢀ1ꢀ(4ꢀmethꢀ
oxyphenyl)ꢀ1Hꢀpyrazoleꢀ3ꢀcarboxylate (9b). Dihydroindazole 2b
(0.25 g) and vinylcyclopropane (0.27 g) gave pyrazoline 8b
(53 mg, 48%) and pyrazole 9b (26 mg, 24%).
= 8.1 Hz, 4J = 4.9 Hz).
Methyl 2ꢀisopropoxyꢀ2ꢀ(4ꢀmethoxyphenyl)hydrazonoacetate
(12). A mixture of dihydroindazole 2b (0.18 g, 0.3 mmol) and
PriOH (3 mL) was heated for 10 h in a sealed tube under Ar at
130 °C. After evaporation of propanꢀ2ꢀol, the target product was
isolated by column chromatography on SiO2 (benzene—EtOAc,
2 : 1). Hydrazone 12 (76 mg) was obtained with admixture of
benzenehexacarboxylate 3 (9—10%) as a colorless oil. MS (EI),
m/z (Irel (%)): 266 [M]+ (10), 224 (15), 164 (60), 149 (15),
137 (18), 122 (100), 84 (60). 1H NMR (CDCl3), δ: 1.35 (d, 6 H,
Compound 8b, colorless crystals, m.p. 112—113 °C (from
C6H6—AcOEt, 10 : 1). Found (%): C, 65.31; H, 6.50; N, 10.01.
C15H18N2O3. Calculated (%): C, 65.68; H, 6.61; N, 10.21. MS
(EI), m/z (Irel (%)): 274 [M]+ (100), 259 [M – Me]+ (10), 243
[M – OMe]+ (8), 233 (15), 215 [M – CO2Me]+ (5), 201 (50),
189 (12), 174 (20), 160 (15), 146 (17), 134 (20), 122 (90). 1H NMR
(CDCl3), δ: 0.24, 0.38, 0.50, 0.62 (all m, 1 H each, CH2CH2);
1.07 (m, 1 H, CH in cycloꢀC3H5); 3.01 (dd, 1 H, Ha(4), 2J= 18.0 Hz,
3J = 6.1 Hz); 3.29 (dd, 1 H, Hb(4), 2J = 18.0 Hz, 3J = 12.0 Hz);
3.80, 3.87 (both s, 3 H each, 2 OMe); 4.06 (ddd, 1 H, H(5),
3J = 6.1 Hz, 3J = 8.0 Hz, 3J = 12.0 Hz); 6.86 (d, 2 H, Hm,
3J = 9.0 Hz); 7.23 (d, 2 H, Ho, 3J = 9.0 Hz). 13C NMR (CDCl3),
δ: 1.8, 6.3 (CH2CH2); 15.2 (CH in cycloꢀC3H5); 37.5 (C(4));
52.1 (CO2Me); 55.6 (OMe); 66.8 (C(5)); 114.3 (Cm); 118.3 (Co);
137.0 (C(3)); 137.4 (Cipso); 155.2 (Cp); 163.6 (COO).
Compound 9b. MS (EI), m/z (Irel (%)): 272 [M]+ (100), 257
[M – Me]+ (20), 241 [M – OMe]+ (35), 225 (45), 213 [M –
– CO2Me]+ (25), 197 (22), 121 (33), 108 (25), 92 (37). 1H NMR
(CDCl3), δ: 0.78, 0.98 (both m, 2 H each, CH2CH2); 1.73
(tt, 1 H, CH in cycloꢀC3H5, Jcis = 8.5 Hz, Jtrans = 5.1 Hz); 3.87
and 3.91 (both s, 3 H each, 2 OMe); 6.98 (d, 2 H, Hm, 3J = 8.9 Hz);
7.50 (d, 2 H, Ho, 3J = 8.9 Hz). 13C NMR (CDCl3), δ: 7.6 (CH in
cycloꢀC3H5); 9.0 (CH2CH2); 52.1 (CO2Me); 55.6 (OMe); 104.9
3
2 Me, J = 7.0 Hz); 3.78, 3.87 (both s, 3 H each, 2 OMe); 4.88
(sept, 1 H, OCH, 3J = 7.0 Hz); 6.85 (m, 2 H, Hm, 3J = 9.0 Hz);
7.08 (m, 2 H, Ho, 3J = 9.0 Hz). 13C NMR (CDCl3), δ: 23.0
(2 Me); 52.5 (CO2Me); 55.7 (OMe); 74.7 (OCH); 114.7 and
114.8 (Co and Cm); 135.5 (Cipso); 137.0 (C=N); 154.6 (Cp);
160.7 (COO).
The authors are grateful to Yu. A. Strelenko (IOCh
RAS) for the methodical help in recording 1H and
13C NMR spectra on a Bruker DRXꢀ500 spectrometer.
This work was financially supported by the Russian
Foundation for Basic Research (Project No. 09ꢀ03ꢀ00636).
References
1. R. Huisgen, Angew. Chem., Int. Ed. (Engl.), 1963, 2,
565, 633.aaa